Elderly do benefit from induction chemotherapy: High dose mitoxantrone based ( “5+1”) induction chemotherapy regimen in newly diagnosed acute myeloid leukemia

In conclusion, HDM based chemotherapy regimen produces high CR rates, is well tolerated and more patients can undergo curative post‐remission therapy including stem cell transplant.This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - November 12, 2018 Category: Hematology Authors: Neeraj Saini, Jan Cerny, Vanessa Furtado, Angela Desmond, Zheng Zhou, Glen Raffel, Imran Puthawala, Jayde Bednarik, Lindsey Shanahan, Patricia Miron, Bruce Woda, Muthalagu Ramanathan, Rajneesh Nath Tags: RESEARCH ARTICLE Source Type: research